Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02433782
What this trial is testing

Myofascial Therapy in Patients With Hemophilic Arthropathy

Who this might be right for
Hemophilia
Universidad Católica San Antonio de Murcia 25
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03744390
What this trial is testing

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia Acute Myeloid
Groupe Francophone des Myelodysplasies 68
Testing effectiveness (Phase 2)Study completedNCT01341262
What this trial is testing

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 378
Not applicableUnknownNCT06258096
What this trial is testing

LI-TASTE Study: Light for Taste

Who this might be right for
Multiple Myeloma
Academic Centre for Dentistry in Amsterdam 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT05975996
What this trial is testing

Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 43
Large-scale testing (Phase 3)UnknownNCT00327262
What this trial is testing

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Central European Leukemia Study Group 240
Early research (Phase 1)UnknownNCT04796688
What this trial is testing

Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphoblastic LeukemiaB-cell Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Early research (Phase 1)Study completedNCT01375842
What this trial is testing

Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsHematologic Malignancies
Genentech, Inc. 661
Testing effectiveness (Phase 2)Ended earlyNCT02464891
What this trial is testing

Complement Inhibition in aHUS Dialysis Patients

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Mario Negri Institute for Pharmacological Research 6
Large-scale testing (Phase 3)Study completedNCT01692418
What this trial is testing

Preoperative Intravenous Iron to Treat Anaemia in Major Surgery

Who this might be right for
Anaemia
University College, London 487
Testing effectiveness (Phase 2)Ended earlyNCT00773890
What this trial is testing

TRF-1101 Assessment in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
TRF Pharma, Inc 80
Testing effectiveness (Phase 2)Study completedNCT02481297
What this trial is testing

Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Who this might be right for
LeukemiaChronic Lymphocytic LeukemiaLymphocytic Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT04552288
What this trial is testing

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Who this might be right for
Solid TumorSolid CarcinomaSolid Tumor, Adult+1 more
Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)Looking for participantsNCT03630991
What this trial is testing

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+15 more
M.D. Anderson Cancer Center 58
Early research (Phase 1)Study completedNCT02892318
What this trial is testing

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05210790
What this trial is testing

Rusfertide in Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Protagonist Therapeutics, Inc. 293
Post-approval studies (Phase 4)Ended earlyNCT00514813
What this trial is testing

Dynepo Long-Term Safety Study

Who this might be right for
AnemiaKidney Failure, Chronic
Shire 152
Post-approval studies (Phase 4)Study completedNCT04985682
What this trial is testing

ADVATE in People With Hemophilia A in India

Who this might be right for
Hemophilia A
Baxalta now part of Shire 50
Not applicableStudy completedNCT02915224
What this trial is testing

Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities

Who this might be right for
Chronic Lymphocytic Leukemia
Hoffmann-La Roche 50
Next Page